Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

linolenic acid/vähk

Link salvestatakse lõikelauale
14 tulemused

Use of .alpha.-linolenic acid metabolites for treatment or prevention of cancer

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION This invention relates to the use of .alpha.-linolenic acid metabolites for the treatment of cancer. More specifically, this invention relates to the use of stearidonic acid for treatment or prevention of cancer, particularly epithelial cell cancers such as, colon cancer,

Iron-containing compositions and method for treating cancer

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF INVENTION The invention relates to iron-containing compositions and methods for the treatment of cancer. PUBLISHED PATENT APPLICATIONS AND GENERAL LITERATURE In previous Patent Applications of the inventor the role of essential fatty acids in cancer, and particularly of gamma-linolenic acid

Iron-containing composition and method for treatment of cancer

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF INVENTION The invention relates to iron-containing compositions and methods for the treatment of cancer. PUBLISHED PATENT APPLICATIONS AND GENERAL LITERATURE In previous Patent Applications of the inventor the role of essential fatty acids in cancer, and particularly of gamma-linolenic acid

Safflower with elevated gamma-linolenic acid

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND OF THE INVENTION Gamma-linolenic acid (GLA) is an essential fatty acid in the omega-6 family that is found primarily in plant-based oils. GLA is synthesized from linoleic acid (LA) via the action of the enzyme delta-six desaturase (.DELTA.6-desaturase). The beneficial effects of GLA

Pharmaceutical and dietary composition

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION This invention relates to the treatment of certain diseases and disorders primarily, but not exclusively, in the field of human medicine and to compositions for use therein. GENERAL BACKGROUND The essential fatty acids (EFAs) are of two types, the n-3 (or .omega.-3) series

Pharmaceutical and dietary composition

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION This invention relates to the treatment of certain diseases and disorders primarily, but not exclusively, in the field of human medicine and to compositions for use therein. GENERAL BACKGROUND The essential fatty acids (EFAs) are of two types, the n-3 (or .omega.-3) series

Pharmaceutical and dietary composition

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION This invention relates to the treatment of certain diseases and disorders primarily, but not exclusively, in the field of human medicine and to compositions for use therein. GENERAL BACKGROUND The essential fatty acids (EFAs) are of two types, the n-3 or (.omega.-3) series

Lipids for treatment of disease

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION This invention relates to the treatment of certain diseases and disorders primarily, but not exclusively, in the field of human medicine and to compositions for use therein. GENERAL BACKGROUND The essential fatty acids (EFAs) are of two types, the n-3 (or .omega.-3) series

Compositions for improving breast health in women

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The present invention relates to compositions containing select combinations of gamma linolenic acid (GLA), iodine, and preferably selenium, for improving breast health in women. BACKGROUND OF THE INVENTION Among the most common health issues affecting women today is that of breast health, most

Pharmaceutical compositions containing interferons and fatty acids

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION The invention relates to the enhancement of the bodily action of interferons. GENERAL BACKGROUND The outline of production of 1-series and 2-series PGs in the body is believed to be as shown in the following diagram: ##STR1## The broad outline of this pathway is well known,

Pharmaceutical and dietary composition

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION This invention relates to the treatment of certain diseases and disorders primarily, but not exclusively, in the field of human medicine and to compositions for use therein. GENERAL BACKGROUND Considerable interest has been shown in recent years in the use of prostaglandin

Method of stabilizing and potentiating the action of anti-angiogenic substances

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION The present invention generally relates to the use of anti-angiogenic agents in the cure of cell proliferative disorders including cancer and other disorders caused by uncontrolled angiogenic activity in the body. More particularly, the invention is directed to the efficacious

Method of stabilizing and potentiating the action of anti-angiogenic substances

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION The present invention generally relates to the use of anti-angiogenic agents in the cure of cell proliferative disorders including cancer and other disorders caused by uncontrolled angiogenic activity in the body. More particularly, the invention is directed to the efficacious

Method of stabilizing and potentiating the action of anti-angiogenic substances

Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FIELD OF THE INVENTION The present invention generally relates to the use of anti-angiogenic agents in the cure of cell proliferative disorders including cancer and other disorders caused by uncontrolled angiogenic activity in the body. More particularly, the invention is directed to the efficacious
Liitu meie
facebooki lehega

Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus

  • Töötab 55 keeles
  • Taimsed ravimid, mida toetab teadus
  • Maitsetaimede äratundmine pildi järgi
  • Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
  • Lugege oma otsinguga seotud teaduspublikatsioone
  • Otsige ravimtaimi nende mõju järgi
  • Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega

Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel

Google Play badgeApp Store badge